Skip to main content

Table 1 Baseline clinical characteristics of all subjects

From: Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris

  Control Diabetes UAP(DM) UAP(non-DM) P Value
(n=36) (n=42) (n=23) (n=34)
Age (years) 59.2 ± 7.5 55.92 ± 14.72 59.3 ± 8.65 60.52 ± 9.86 NS
Male, n (%) 21 (58) 23 (57) 14 (61) 22 (64) NS
Smoking, n (%) 11 (30) 13 (31) 8 (34) 13 (38) NS
Hypertension n (%) 0 (0) 17 (40) 14 (60) 18 (53) < 0.01
Total cholesterol (mmol/l) 4.37 ± 1.23 4.69 ± 1.02 4.40 ± 1.12 4.62 ± 1.35 NS
HDL cholesterol (mmol/l) 1.25 ± 0.46 1.30 ± 0.40 1.32 ± 0.42 1.53 ± 0.54 NS
LDL cholesterol (mmol/l) 2.83 ± 0.96 3.07 ± 0.823 2.53 ± 1.44 2.75 ± 1.05 NS
Triglycerides (mmol/l) 1.65 ± 1.32 1.95 ± 1.50 1.89 ± 1.76 1.79 ± 1.68 NS
HbA1c (%) - 9.09 ± 3.01 8.33 ± 3.52 5.62 ± 0.86 < 0.01
FBG (mmol/L) 5.36 ± 1.82 11.84 ± 6.67 8.3 ± 4.1 6.13 ± 1.34 < 0.01
PBG2h (mmol/L) - 14.55 ± 7.75 11.23 ± 6.31 7.32 ± 1.51 < 0.01
Diabetes duration (year) - 5.61 ± 2.95 6.48 ± 3.62 - NS
Medications, n (%)
Insulin - 6 (14) 3 (13) - NS
Antidiabetics - 19 (45) 13 (56) - NS
Statin - 15 (35) 19 (83) 26 (76) < 0.01
Aspirin - 17 (40) 21 (91) 29 (85) < 0.01
Clopidogrel - 0 (0) 5 (22) 6 (18) < 0.01
ACE inhibitor - 11 (26) 12 (52) 16 (47) < 0.01
Beta-receptors blocker - 3 (7) 7 (30) 13 (38) < 0.01
Nitroglycerin - 0 (0) 8 (35) 13 (38) < 0.01